THR-beta agonist 2 diacetate (Compound 3) is a potent agonist of THR-beta. THR-beta agonist 2 diacetate has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases[1].
Molekulargewicht:
563.30
Formel:
C22H16Cl2N6O8
Target-Kategorie:
Thyroid Hormone Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
